JP2001518523A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001518523A5 JP2001518523A5 JP2000514677A JP2000514677A JP2001518523A5 JP 2001518523 A5 JP2001518523 A5 JP 2001518523A5 JP 2000514677 A JP2000514677 A JP 2000514677A JP 2000514677 A JP2000514677 A JP 2000514677A JP 2001518523 A5 JP2001518523 A5 JP 2001518523A5
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- contrast agent
- state
- composition
- compositions described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94298997A | 1997-10-02 | 1997-10-02 | |
| US08/942,989 | 1997-10-02 | ||
| PCT/US1998/020182 WO1999017809A2 (en) | 1997-10-02 | 1998-09-24 | Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005276942A Division JP2006077020A (ja) | 1997-10-02 | 2005-09-22 | インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001518523A JP2001518523A (ja) | 2001-10-16 |
| JP2001518523A5 true JP2001518523A5 (https=) | 2006-01-05 |
Family
ID=25478927
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000514677A Pending JP2001518523A (ja) | 1997-10-02 | 1998-09-24 | インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法 |
| JP2005276942A Pending JP2006077020A (ja) | 1997-10-02 | 2005-09-22 | インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005276942A Pending JP2006077020A (ja) | 1997-10-02 | 2005-09-22 | インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6861045B1 (https=) |
| EP (1) | EP1019094B1 (https=) |
| JP (2) | JP2001518523A (https=) |
| KR (1) | KR20010030854A (https=) |
| AT (1) | ATE254479T1 (https=) |
| AU (1) | AU742438C (https=) |
| BR (1) | BR9812716A (https=) |
| CA (1) | CA2303426C (https=) |
| DE (1) | DE69819925T2 (https=) |
| DK (1) | DK1019094T3 (https=) |
| ES (1) | ES2206996T3 (https=) |
| HU (1) | HUP0101245A3 (https=) |
| IL (1) | IL134985A0 (https=) |
| IS (1) | IS2041B (https=) |
| NO (1) | NO321966B1 (https=) |
| NZ (1) | NZ503402A (https=) |
| PT (1) | PT1019094E (https=) |
| SK (1) | SK4842000A3 (https=) |
| WO (1) | WO1999017809A2 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495118B1 (en) | 1997-09-26 | 2002-12-17 | Schering Aktiengesellschaft | Lipophilic metal complexes for necrosis and infarction imaging |
| KR20010030854A (ko) * | 1997-10-02 | 2001-04-16 | 로퍼, 랜달 비. | 인터벤셔날 요법을 모니터하기 위한 콘트라스트 강화된진단 영상화 방법 |
| US6167297A (en) * | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
| AU1791501A (en) | 1999-11-22 | 2001-06-04 | Epix Medical, Inc. | Imaging sexual response |
| EP1251876A2 (en) * | 2000-01-22 | 2002-10-30 | Epix Medical, Inc. | Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage |
| TWI221406B (en) | 2001-07-30 | 2004-10-01 | Epix Medical Inc | Systems and methods for targeted magnetic resonance imaging of the vascular system |
| JP2004537580A (ja) * | 2001-08-10 | 2004-12-16 | エピックス メディカル， インコーポレイテッド | 延長された循環半減期を有するポリペプチド結合体 |
| US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
| US20050100963A1 (en) | 2002-03-01 | 2005-05-12 | Dyax Corporation | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| CA2666005C (en) | 2002-03-01 | 2016-01-19 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| PT2949658T (pt) | 2003-03-03 | 2018-10-18 | Bracco Suisse Sa | Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos |
| US20050064045A1 (en) * | 2003-09-18 | 2005-03-24 | Sheng-Ping Zhong | Injectable therapeutic formulations |
| WO2005110495A1 (en) * | 2004-05-18 | 2005-11-24 | Siemens Aktiengesellschaft | Biomolecular contrast agents for therapy control in radiation therapy with proton or ion beams |
| US7585492B2 (en) | 2004-05-18 | 2009-09-08 | Siemens Aktiengesellschaft | Biomolecular contrast agents for therapy success and dose monitoring in radiation therapy with proton or ion beams |
| JP2006248978A (ja) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
| CN101317100A (zh) * | 2005-11-29 | 2008-12-03 | 皇家飞利浦电子股份有限公司 | 使用磁共振区分结合和未结合造影剂 |
| WO2007073792A1 (de) * | 2005-12-19 | 2007-07-05 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur herstellung von 4,4-diphenylcyclohexanol |
| KR101336505B1 (ko) | 2006-08-17 | 2013-12-05 | 에픽스 파마슈티칼스, 인코포레이티드 | 림프계의 영상화 방법 |
| DE102006049821A1 (de) | 2006-10-18 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung |
| US20100092389A1 (en) * | 2008-10-10 | 2010-04-15 | The General Hospital Corporation | Detection of atherosclerosis using indocyanine green |
| US9423480B2 (en) * | 2008-10-27 | 2016-08-23 | The University Of Western Ontario | System and method for magnetic resonance imaging |
| WO2010121133A2 (en) | 2009-04-17 | 2010-10-21 | The General Hospital Corporation | Multimodal imaging of fibrin |
| EP2408790A1 (en) | 2009-03-19 | 2012-01-25 | Wyeth LLC | Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof |
| WO2011095898A1 (en) | 2010-02-02 | 2011-08-11 | Koninklijke Philips Electronics N.V. | Functional imaging |
| AU2012282678B2 (en) | 2011-07-11 | 2016-03-03 | California Institute Of Technology | Akt-specific capture agents, compositions, and methods of using and making |
| TW201514188A (zh) | 2013-03-13 | 2015-04-16 | Lantheus Medical Imaging Inc | 製備釓磷維塞三鈉單水合物之方法 |
| US11160454B2 (en) * | 2013-04-08 | 2021-11-02 | Sunnybrook Research Institute | System and method for imaging biomarkers indicative of cardiac thermal ablation lesions |
| JP2015087167A (ja) * | 2013-10-29 | 2015-05-07 | キヤノン株式会社 | 画像処理方法、画像処理システム |
| US10314648B2 (en) | 2013-12-13 | 2019-06-11 | The Trustees of the Universoty of Pennsylvania | Coaxial ablation probe and method and system for real-time monitoring of ablation therapy |
| WO2015171543A1 (en) | 2014-05-05 | 2015-11-12 | California Institute Of Technology | Mutant akt-specific capture agents, compositions, and methods of using and making |
| WO2015196208A2 (en) | 2014-06-20 | 2015-12-23 | The General Hospital Corporation | Collagen targeted imaging probes |
| EP3270951B1 (en) | 2015-03-16 | 2020-09-09 | California Institute of Technology | Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making |
| CN115112898B (zh) | 2015-07-15 | 2026-03-24 | 加州理工学院 | Il-17f-特异性捕获剂、组合物以及使用和制造的方法 |
| US10383590B2 (en) | 2015-09-28 | 2019-08-20 | General Electric Company | Methods and systems for adaptive scan control |
| CN115109120A (zh) | 2016-04-04 | 2022-09-27 | 英蒂分子公司 | Cd8-特异性捕获剂、组合物及使用和制备方法 |
| US11884707B2 (en) | 2016-09-29 | 2024-01-30 | Regeneron Pharmaceuticals, Inc. | Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same |
| EP3535278A4 (en) | 2016-11-01 | 2020-06-24 | Ohio State Innovation Foundation | METHOD FOR IODING BIOMOLECULES |
| EP3638687A1 (en) | 2017-06-15 | 2020-04-22 | Indi Molecular, Inc. | Il-17f and il-17a-specific capture agents, compositions, and methods of using and making |
| US20190370956A1 (en) | 2018-05-30 | 2019-12-05 | General Electric Company | Contrast imaging system and method |
| WO2020093055A2 (en) | 2018-11-02 | 2020-05-07 | Indi Molecular, Inc. | Peptide libraries with non-canonical amino acids |
| US11638764B2 (en) | 2018-11-08 | 2023-05-02 | Indi Molecular, Inc. | Theranostic capture agents, compositions, and methods of using and making |
| US12201679B2 (en) | 2019-04-05 | 2025-01-21 | Institute For Systems Biology | Epitope-targeted peptide immunostimulants |
| WO2020236969A1 (en) | 2019-05-20 | 2020-11-26 | Indi Molecular, Inc. | Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1) |
| US11414460B2 (en) | 2019-07-19 | 2022-08-16 | Institute For Systems Biology | KRAS-specific capture agents, compositions, and methods of making and using |
| EP4143227A2 (en) | 2020-04-30 | 2023-03-08 | Sairopa B.V. | Anti-cd103 antibodies |
| US12209142B2 (en) | 2020-05-29 | 2025-01-28 | Institute For Systems Biology | SARS-CoV-2 epitope-targeted peptide immunostimulants |
| WO2022098743A1 (en) | 2020-11-03 | 2022-05-12 | Indi Molecular, Inc. | Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250285A (en) | 1985-05-08 | 1993-10-05 | The General Hospital Corporation | Hydroxy-aryl metal chelates for diagnostic NMR imaging |
| US5094848A (en) | 1989-06-30 | 1992-03-10 | Neorx Corporation | Cleavable diphosphate and amidated diphosphate linkers |
| IT1269839B (it) | 1994-05-26 | 1997-04-15 | Bracco Spa | Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi |
| TW319763B (https=) * | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
| CA2539215A1 (en) | 1995-02-01 | 1996-08-08 | Epix Pharmaceuticals, Inc. | Diagnostic imaging contrast agents with extended blood retention |
| DE19529512C2 (de) | 1995-08-10 | 2000-11-23 | Siemens Ag | Verfahren zur Phasenkontrast-MR-Angiographie und Anordnung zur Durchführung des Verfahrens |
| DE19543785A1 (de) | 1995-11-24 | 1997-05-28 | Philips Patentverwaltung | MR-Verfahren und Anordnung zur Durchführung des Verfahrens |
| AU726914B2 (en) * | 1996-04-01 | 2000-11-23 | Epix Pharmaceuticals, Inc. | Bioactivated diagnostic imaging contrast agents |
| IT1283650B1 (it) | 1996-08-02 | 1998-04-23 | Bracco Spa | Chelati paramagnetici ad alta relassivita' in siero |
| US5919967A (en) | 1997-04-11 | 1999-07-06 | Epix Medical, Inc. | Process for synthesizing phosphodiesters |
| KR20010030854A (ko) * | 1997-10-02 | 2001-04-16 | 로퍼, 랜달 비. | 인터벤셔날 요법을 모니터하기 위한 콘트라스트 강화된진단 영상화 방법 |
| IT1304501B1 (it) | 1998-12-23 | 2001-03-19 | Bracco Spa | Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza |
-
1998
- 1998-09-24 KR KR1020007003527A patent/KR20010030854A/ko not_active Ceased
- 1998-09-24 ES ES98950704T patent/ES2206996T3/es not_active Expired - Lifetime
- 1998-09-24 AU AU96686/98A patent/AU742438C/en not_active Ceased
- 1998-09-24 WO PCT/US1998/020182 patent/WO1999017809A2/en not_active Ceased
- 1998-09-24 DE DE69819925T patent/DE69819925T2/de not_active Expired - Lifetime
- 1998-09-24 BR BR9812716-0A patent/BR9812716A/pt not_active Application Discontinuation
- 1998-09-24 NZ NZ503402A patent/NZ503402A/en unknown
- 1998-09-24 SK SK484-2000A patent/SK4842000A3/sk unknown
- 1998-09-24 IL IL13498598A patent/IL134985A0/xx not_active IP Right Cessation
- 1998-09-24 PT PT98950704T patent/PT1019094E/pt unknown
- 1998-09-24 JP JP2000514677A patent/JP2001518523A/ja active Pending
- 1998-09-24 CA CA002303426A patent/CA2303426C/en not_active Expired - Fee Related
- 1998-09-24 AT AT98950704T patent/ATE254479T1/de not_active IP Right Cessation
- 1998-09-24 HU HU0101245A patent/HUP0101245A3/hu unknown
- 1998-09-24 EP EP98950704A patent/EP1019094B1/en not_active Expired - Lifetime
- 1998-09-24 DK DK98950704T patent/DK1019094T3/da active
-
2000
- 2000-03-10 IS IS5399A patent/IS2041B/is unknown
- 2000-04-03 NO NO20001707A patent/NO321966B1/no not_active IP Right Cessation
- 2000-09-08 US US09/887,706 patent/US6861045B1/en not_active Expired - Fee Related
-
2004
- 2004-10-08 US US10/961,872 patent/US7175829B2/en not_active Expired - Fee Related
-
2005
- 2005-09-22 JP JP2005276942A patent/JP2006077020A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001518523A5 (https=) | ||
| EP0414700B1 (en) | Contrast agents for magnetic resonance imaging | |
| JP2003505519A5 (https=) | ||
| US7727512B2 (en) | Chelating agents with lipophilic carriers | |
| EP0222886B1 (en) | Hepatobiliary nmr contrast agents | |
| CA2474386A1 (en) | Integrin targeted imaging agents | |
| US5466439A (en) | Polymeric contrast enhancing agents for magnetic resonance images | |
| MXPA02001017A (es) | Agente multimerico de formacion de imagenes con especificidad hacia el blanco mediante su union a multiples regiones. | |
| WO2002028441A3 (en) | Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits | |
| IL164254A (en) | Para-magnetic particles that provide enhanced relaxation | |
| JP2001518523A (ja) | インターベンショナル療法をモニタリングするためのコントラスト増強型診断的画像化方法 | |
| CA2108362A1 (en) | Melanin-based agents for image enhancement | |
| WO2002007846A1 (en) | Extended organic cobalt and nickel magnetic complexes | |
| AU732900B2 (en) | Liver function test | |
| CN101528124A (zh) | 用于淋巴系统成像的方法 | |
| Thonon et al. | A gadolinium triacetic monoamide DOTA derivative with a methanethiosulfonate anchor group. Relaxivity properties and conjugation with albumin and thiolated particles | |
| JP4891763B2 (ja) | 「ｃｅｓｔ」用途のための、磁気共鳴シフト試薬と交換性プロトンを含有する基質との付加物 | |
| CA2514201A1 (en) | Chelating agents with lipophilic carriers | |
| US5961953A (en) | Magnetic resonance blood pool agents | |
| Chakravarty et al. | Magnets, Magnetism, and Magnetic Resonance Imaging: History, Basics, Clinical Aspects, and Future Directions | |
| US20050201943A1 (en) | Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage | |
| WO1997030734A1 (en) | Magnetic resonance blood pool agents | |
| WO2025189063A1 (en) | Materials and methods for detecting senescent cells | |
| Fransen et al. | r1 and r2 Relaxivities of Dendrons Based on a OEG‐DTPA Architecture: Effect of Gd3+ Placement and Dendron Functionalization | |
| Fransen et al. | Research Article 𝑟1and 𝑟2 Relaxivities of Dendrons Based on a OEG-DTPA Architecture: Effect of Gd 3 Placement and Dendron Functionalization |